The EMPA-KIDNEY, Collaborative G, Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R
These patients warrant either baseline supplementation or at minimum testing b12 levels every 6 to 12 months during treatment to catch declining levels before deficiency develops
040621352 Product Name ATP 12.5mg/Ml 50ml Supplier Type Manufacturer Container Type Single Dose Vial Storage Instructions Store in Cool, Dry & Dark Place Protect From Direc Transport Package Bottle or Plastic Glass Production Capacity 10000000 Packaging & Delivery Package Size 15.00cm * 18.00cm * 34.00cm Package Gross Weight 13.784kg Product Description Prevention and treatment of magnesium deficiency- Treatment of muscle disorder, fatigue, convalescence
Therefore, elucidating the mechanisms through which GSH is involved in ATG and/or apoptosis will be crucial to develop advanced therapies to counteract or ameliorate such diseases
